David M. Clarke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
David M. Clarke has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Tip W. Loo
Department of Medicine and Department of Biochemistry, University of Toronto, Toronto, Ontario M5S 1A8, Canada
103 shared publications M. Claire Bartlett
45 shared publicationsYing Wang
Department of Medicine, University of Toronto, Toronto, Ontario M5S 1A8, Canada
5 shared publicationsFabian S. Seibert
Department of Medicine, University of Toronto, Ontario, Canada
4 shared publicationsJohn R. Riordan
Johnson Medical Research Center, Mayo Clinic
4 shared publicationsGeri A. Sawada
Drug Disposition, Eli Lilly and Company, Indianapolis, Indiana 46285
3 shared publications
Latest Publications
- 1 December 2017
- Published by Elsevier in Biochemical Pharmacology
- Vol. 145, 27-33
A short cross-linker activates human P-glycoprotein missing a catalytic carboxylate
- 1 December 2017
- Published by Elsevier in Biochemical Pharmacology
- Vol. 145, 27-33
A short cross-linker activates human P-glycoprotein missing a catalytic carboxylate
- 1 July 2017
- Published by Elsevier in Biochemical Pharmacology
- Vol. 136, 24-31
Corrector VX-809 promotes interactions between cytoplasmic loop one and the first nucleotide-binding domain of CFTR
- 1 July 2017
- Published by Elsevier in Biochemical Pharmacology
- Vol. 136, 24-31
Corrector VX-809 promotes interactions between cytoplasmic loop one and the first nucleotide-binding domain of CFTR
- 1 January 2017
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 483 (1) , 366-370
Attachment of a ‘molecular spring’ restores drug-stimulated ATPase activity to P -glycoprotein lacking both Q loop glutamines
- 1 January 2017
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 483 (1) , 366-370
Attachment of a ‘molecular spring’ restores drug-stimulated ATPase activity to P -glycoprotein lacking both Q loop glutamines
- Open Access
- 11 May 2016
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 55 (20) , 2817-2820
Drugs Modulate Interactions between the First Nucleotide-Binding Domain and the Fourth Cytoplasmic Loop of Human P-Glycoprotein
Drug substrates stimulate ATPase activity of the P-glycoprotein (P-gp) ATP-binding cassette drug pump by an unknown mechanism. Cross-linking analysis was performed to test if drug substrates stimulate P-gp ATPase activity by altering cross-talk at the first transmission interface linking the drug-binding [intracellular loop 4 (S909C)] and first nucleotide-binding domains [NBD1 (V472C or L443C)]. In the absence of lipid (inactive P-gp), only V472C/S909C showed cross-linking. Drugs blocked V472C/S909C cross-linking. In the presence of lipids (active P-gp), drug substrates promoted only L443C/S909C cross-linking. This suggests that drug substrates stimulate ATPase activity through a conformational change that shifts Ser909 away from Val472 and toward Leu443.
- 11 May 2016
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 55 (20) , 2817-2820
Open AccessDrugs Modulate Interactions between the First Nucleotide-Binding Domain and the Fourth Cytoplasmic Loop of Human P-Glycoprotein
Drug substrates stimulate ATPase activity of the P-glycoprotein (P-gp) ATP-binding cassette drug pump by an unknown mechanism. Cross-linking analysis was performed to test if drug substrates stimulate P-gp ATPase activity by altering cross-talk at the first transmission interface linking the drug-binding [intracellular loop 4 (S909C)] and first nucleotide-binding domains [NBD1 (V472C or L443C)]. In the absence of lipid (inactive P-gp), only V472C/S909C showed cross-linking. Drugs blocked V472C/S909C cross-linking. In the presence of lipids (active P-gp), drug substrates promoted only L443C/S909C cross-linking. This suggests that drug substrates stimulate ATPase activity through a conformational change that shifts Ser909 away from Val472 and toward Leu443.
- Open Access
- 1 April 2016
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 472 (2) , 379-383
P-glycoprotein ATPase activity requires lipids to activate a switch at the first transmission interface
- 1 April 2016
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 472 (2) , 379-383
Open AccessP-glycoprotein ATPase activity requires lipids to activate a switch at the first transmission interface
- Open Access
- 1 December 2015
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (49) , 29389-29401
Mapping the Binding Site of the Inhibitor Tariquidar That Stabilizes the First Transmembrane Domain of P-glycoprotein
- 1 December 2015
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (49) , 29389-29401
Open AccessMapping the Binding Site of the Inhibitor Tariquidar That Stabilizes the First Transmembrane Domain of P-glycoprotein
- Open Access
- 1 July 2015
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (27) , 16954-16963
The Transmission Interfaces Contribute Asymmetrically to the Assembly and Activity of Human P-glycoprotein
- 1 July 2015
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (27) , 16954-16963
Open AccessThe Transmission Interfaces Contribute Asymmetrically to the Assembly and Activity of Human P-glycoprotein
- 1 December 2014
- Published by Elsevier in Biochemical Pharmacology
- Vol. 92 (4) , 558-566
Tariquidar inhibits P-glycoprotein drug efflux but activates ATPase activity by blocking transition to an open conformation
- 1 December 2014
- Published by Elsevier in Biochemical Pharmacology
- Vol. 92 (4) , 558-566
Tariquidar inhibits P-glycoprotein drug efflux but activates ATPase activity by blocking transition to an open conformation
- Open Access
- 1 September 2014
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 289 (36) , 24749-24758
Cysteines Introduced into Extracellular Loops 1 and 4 of Human P-Glycoprotein That Are Close Only in the Open Conformation Spontaneously Form a Disulfide Bond That Inhibits Drug Efflux and ATPase Activity
- 1 September 2014
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 289 (36) , 24749-24758
Open AccessCysteines Introduced into Extracellular Loops 1 and 4 of Human P-Glycoprotein That Are Close Only in the Open Conformation Spontaneously Form a Disulfide Bond That Inhibits Drug Efflux and ATPase Activity